Company Overview and News

Is Dollarama's Weak Quarter A Warning Sign?

2018-06-22 seekingalpha
The company continues to operate efficiently, with an SG&A expense as a percentage of total sales that was lower than last year.

Canadian Dividend All-Stars Expected To Announce Dividend Increases - Week Of April 23

2018-04-23 seekingalpha
It’s been a slow month of April for dividend raises, and this is the first Canadian Dividend All-Star article in a few weeks. Fear not, as with earnings season ramping up, so too will the dividend raises. This week, there are thirteen Canadian Dividend All-Stars scheduled to report earnings. Of those, only one is expected to announce a raise. Before we look ahead, let’s take a look at the results from the past few weeks.

Dollarama: Buy Or Hold?

2018-03-31 seekingalpha
The company operates its business efficiently and has an ambitious plan to expand its business in the next decade.

Related Articles

HIMX: Himax Technologies Analysis and Research Report

3h - Asif

History and Development Himax Taiwan, its predecessor, was incorporated on June 12, 2001 as a limited liability company under the laws of the ROC. On April 26, 2005, the company established Himax Technologies Limited, an exempted company with limited liability under the Cayman Islands Companies Law, as a holding company to hold the shares of Himax Taiwan in connection with its reorganization and share exchange. On October 14, 2005, Himax Taiwan became its wholly owned subsidiary through a share exchange consummated pursuant to the ROC Business Mergers and Acquisitions Law through which the company acquired all of the issued and outstanding shares of Himax Taiwan, and the company issued ordinary shares to the shareholders of Himax Taiwan. Shareholders of Himax Taiwan received one of its ordinary shares in exchange for one Himax Taiwan common share. The share exchange was unanimously approved by shareholders of Himax Taiwan on June 10, 2005 with no dissenting shareholders and by ...

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

Silicon Investor Message Boards

This table lists all message boards related to TSX:DOL / Dollarama Inc on message board site Silicon Investor.

MELI MercadoLibre The coming US dollar crisis
DLB Dolby Laboratories DG: Dollar General Corp.
IRO.V - Inter-Rock Minerals Inc.(Dolomite Supplier) Dolly Varden
Kelly or Justin, who really is Americau0027s Idol? Dollar Exchange Rates
Rudolph Technologies Inc-(RTEC) Dollar and Under Sleeper Stocks